Paraneoplastic hyperleucocytosis in a melanoma patient after initiation of ipilimumab and nivolumab combination therapy

Overview of attention for article published in Journal for Immunotherapy of Cancer, October 2018

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (63rd percentile)

So far, Altmetric has seen 13 X posts from 7 X users, with an upper bound of 22,418 followers.

RT @sitcancer: #JITC Case Report: Paraneoplastic hyperleucocytosis in a melanoma patient after initiation of ipilimumab and nivolumab combi…

#JITC Case Report: Paraneoplastic hyperleucocytosis in a melanoma patient after initiation of ipilimumab and nivolumab combination therapy https://t.co/Idw7AKX2H0 https://t.co/0YroECtK7c

RT @sitcancer: #JITC Case Report: Paraneoplastic hyperleucocytosis in a melanoma patient after initiation of ipilimumab and nivolumab combi…

RT @sitcancer: #JITC Case Report: Paraneoplastic hyperleucocytosis in a melanoma patient after initiation of ipilimumab and nivolumab combi…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 9 additional X posts.